The rate of celiac disease prevalence has been steadily rising. According to a study comparing the stored blood of soldiers with people today, it has increased up to four times within the past 50 years. Looking for the reason behind such a significant rise, many papers have been published investigating possible environmental causes, including one that found a link between celiac disease and an absence of H. pylori in the stomach. Another paper, involving three of the same doctors, including Celiac Disease Foundation’s own Medical Advisory Board Member Dr. Peter Green, found another possible explanation.
Alex Morris may only be 12, but the seventh grader is going well beyond her years in organizing a 5K race to benefit a celiac disease charity.
Alex, a student at Naperville’s Washington Junior High, like many Americans, suffers from the incurable autoimmune disorder gluten-sensitive enteropathy that commonly is treated by abstaining from foods containing wheat products.
Eating nothing but gluten-free foods requires self-discipline. But people who have celiac disease must follow the strict diet or face the consequences, says Danielle Nebel, a junior at Calabasas High School who was diagnosed with the autoimmune disorder when she was 2½ years old.
A recent study, published by The American Journal of Gastroenterology has uncovered a new potential method for treating celiac disease. The study, titled “Novel Role of the Serine Protease Inhibitor Elafin in Gluten-Related Disorders” was first published online on April 8th, 2014. It’s authors, doctors and scientists hailing from all over the world, looked at several different aspects of a protein called elafin and its effect on gluten-related disorders like celiac disease.
A study recently published by The Journal of the American Medical Association has found further evidence for a link between celiac disease and irritable bowel syndrome (IBS). The study, first posted online on April 21, 2014, titled “Increased Prevalence of Celiac Disease Among Pediatric Patients With Irritable Bowel Syndrome” examined nearly a thousand Italian children […]
Compared with the general population, individuals with celiac disease were almost twice as likely to have CAD, according to a large retrospective study presented here today at the American College of Cardiology (ACC) 2014 Scientific Sessions . Even patients younger than aged 65 years were at higher risk.
By Van Waffle | February 24, 2014 Despite a growing awareness of celiac disease, most people still don’t know they have it. When a pediatrician phoned Marilyn Geller with test results indicating her 15-year-old son probably had celiac disease, Geller did not understand what the physician was saying. With a master’s of science in public health […]
Dole Packaged Foods announced today that they are now a proud sponsor of Celiac Disease Foundation (CDF), a national nonprofit organization dedicated to driving early diagnosis and treatment of celiac disease through advocacy, education and advancing research to improve the quality of life for all people affected by gluten-related disorders.
The Alcohol and Tobacco Tax and Trade Bureau (TTB) made a new ruling on how alcohol products can be labeled with respect to gluten. The TTB’s revised ruling on the matter, for the most part, is in line with the FDA.
A new study, with contributions made from two CDF Medical Advisory Board Members, Martin Kagnoff and Joseph A. Murray, has identified antibody biomarkers that can be potentially used to diagnose nonresponsive celiac disease.